Skip to main content
. 2010 Dec 16;2(1):62–72. doi: 10.1007/s12672-010-0056-0

Table 2.

Distribution of circulating hormone levels in study participants (N = 257), Madison, Wisconsin, 2008–2009

Mean Standard deviation Q1 Median Q3 Range Correlationa with BMI (P value)
Estradiol (pg/mL) 10.1 5.8 6.0 8.8 12.4 2.8, 33.9 0.49 (<0.0001)
Free estradiol (pg/mL) 0.27 0.17 0.14 0.23 0.34 0.03, 0.98 0.57 (<0.0001)
Bioavailable estradiol (pg/mL) 6.8 4.4 3.6 5.9 8.7 0.7, 24.8 0.57 (<0.0001)
Estrone (pg/mL) 29.3 14.2 19.1 26.1 36.9 6.0, 86.4 0.37 (<0.0001)
Estrone sulfate (ng/mL) 0.73 0.29 0.54 0.68 0.88 0.21, 2.00 0.18 (0.004)
Testosterone (ng/dL)b 22.8 11.5 14.4 19.7 28.0 4.0, 81.6 0.01 (0.84)
Free testosterone (pg/mL)b 4.7 2.5 2.9 4.1 6.0 0.8, 16.2 0.24 (<0.001)
Bioavailable testosterone (ng/dL)b 11.5 6.1 7.2 10.2 14.8 1.9, 39.8 0.24 (<0.001)
Progesterone (pg/mL) 48.5 23.5 33.0 44.7 59.2 8.0, 181.1 −0.18 (0.004)
Sex hormone binding globulin (nmol/L) 44.6 23.3 29.7 40.1 54.2 5.2, 197.0 −0.54 (<0.0001)

Q1 first quartile; Q3 third quartile; BMI body mass index

aSpearman correlation coefficient

bTestosterone values were missing for three subjects